Arrowstreet Capital Limited Partnership increased its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 697.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 7,357 shares of the biotechnology company's stock after acquiring an additional 6,434 shares during the period. Arrowstreet Capital Limited Partnership's holdings in Axon Enterprise were worth $4,372,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in AXON. Vanguard Group Inc. lifted its stake in shares of Axon Enterprise by 3.4% in the fourth quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock worth $5,019,886,000 after buying an additional 275,959 shares in the last quarter. Geode Capital Management LLC boosted its stake in Axon Enterprise by 2.0% during the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company's stock worth $710,103,000 after buying an additional 35,320 shares during the period. Norges Bank acquired a new position in Axon Enterprise during the fourth quarter worth $482,081,000. GQG Partners LLC acquired a new position in Axon Enterprise in the 4th quarter valued at about $478,349,000. Finally, Groupama Asset Managment purchased a new stake in Axon Enterprise during the 3rd quarter worth approximately $200,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on the company. JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Craig Hallum downgraded Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. TD Cowen initiated coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price target on the stock. Northcoast Research lowered shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. Finally, The Goldman Sachs Group upped their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and ten have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $626.45.
View Our Latest Stock Report on AXON
Axon Enterprise Stock Up 2.9 %
Shares of Axon Enterprise stock traded up $16.38 during trading on Monday, reaching $584.36. The company had a trading volume of 65,933 shares, compared to its average volume of 804,717. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99. The firm's fifty day moving average is $567.07 and its 200-day moving average is $561.71. The company has a market cap of $44.78 billion, a price-to-earnings ratio of 151.00, a price-to-earnings-growth ratio of 5.17 and a beta of 1.13.
Insider Transactions at Axon Enterprise
In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the firm's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the sale, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 6.10% of the company's stock.
Axon Enterprise Company Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
See Also
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
